Locemia Solutions ULC
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Locemia Solutions ULC
Pharma and the US biotech will target key regulators of cellular metabolism with focus on immune and neurological disorders. Royalty Pharma buys portion of PTC’s royalty rights to risdiplam, under development at Roche.
The latest drug development news and highlights from our US FDA Performance Tracker.
BioVentures Investors is to invest in early stage medical device and diagnostics companies after closing its fourth – and largest – fund.
Eli Lilly leads the way in diabetes and is using its current portfolio to find advantageous opportunities in related therapeutic areas.
- Specialty Pharmaceuticals
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.